H. GEORGE NURNBERG, M.D.

Department of
Psychiatry

PROFESSOR
INTERIM CHAIR, DEPARTMENT OF PSYCHIATRY

M.D., Upstate Medical College at Syracuse, 1968
Internship / Resident, Internal Medicine, New York Hospital-Cornell University, 1968 -1970
Residency, Psychiatry, New York Hospital-Cornell Medical College - Payne Whitney Clinic, 1970-1972
Psychiatry Fellow, New York Hospital-Cornell University Medical College, Payne Whitney Clinic, 1972

E-mail: geon@unm.edu  

Areas of Specialization: Personality disorders; Affective disorders; Pharmacology; Nosology–Classification; Novel (NANC )Signaling; Research Methodology;  Psychoanalysis and Psychodynamic Psychotherapy

Selected Publications: (among 200)

1.            Nurnberg HG, Martin GA and Pollack S (1994).  An empirical method to refine personality disorder classification using stepwise logistic regression modeling to develop diagnostic criteria and diagnostic thresholds.  Comprehensive Psychiatry 35(6):409-419.

2.            Nurnberg HG, Levine PE, Pollack S, Raskin M, Siegel O and Prince R (1992).  Comorbidity of borderline personality disorder and other Axis II personality disorders.  Psychiatry Digest 6(10):11-12.

3.            Nurnberg HG, Bogenschutz M. Classification of mental disorders. (1998) In Comprehensive Textbook of Psychiatry, Seventh Edition, 824-839. HI Kaplan, SY Saddock, Editors. Williams and Wilkins, New York, NY.

4.            Nurnberg HG, Woodbury M, Bogenschutz MP (1999).  A mathematical typology analysis of DSM‑III-R personality disorder classification: Grade of membership technique. Comprehensive Psychiatry 40(1):61-71.

5.            Nurnberg HG, Thompson PM, Hensley PL (1999).  Antidepressant medication change in a clinical treatment setting:  a comparison of the effectiveness of selective serotonin reuptake inhibitors. J Clin Psychiatry 60 (9): 574-579.

6.            Nurnberg HG, Hensley P, Gelenberg A, Fava M, Lauriello J, Paine S. (2003) Treatment of antidepressant-associated sexual dysfunction with sildenafil:  a randomized controlled trial. JAMA 289 (1): 56-64.

7.            Nurnberg HG, Hensley PL, Paine S. (2003) Discriminating treatment effects of sildenafil on       orgasm delay and erectile dysfunction in serotonergic antidepressant-associated sexual dysfunction. The Journal of Urology, 169 (Suppl 4): 376.

8.            Nurnberg HG, Hensley PL. (2003)  Viagra (Sildenafil Citrate) in Serotonergic Reuptake Inhibitor-Associated Female Sexual Dysfunction. Progrés en Urologie, Journal of the French Urology Association, Vol.13, (Suppl 2);3: p.26

9.            Nurnberg HG, Fava M, Seidman S, Holloway W, Farmer M, Nicholas S, Stecher V. (2003) Efficacy and Safety of Viagra, (Sildenafil Citrate) in Men with Serotonergic Antidepressant-Associated Erectile Dysfunction: Results of a Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Progrés en Urologie, Journal of the French Urology Association, Vol.13, (Suppl 2); 3: p.27

10.         Nurnberg HG., Guest Editor. (2003) (Introduction)  Erectile dysfunction and comorbid depression: prevalence, treatment strategies, and associated medical conditions. Journal of Clinical Psychiatry, 64 (suppl 10):3-4

11.         Nurnberg HG, Hensley PL. (2003) Sildenafil citrate for the management of antidepressant-associated erectile dysfunction. Journal of Clinical Psychiatry, 64 (suppl 10):20-25

12.         Nurnberg HG, Duttagupta S. (2004) Economic analysis of Sildenafil Citrate (Viagra) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor use. (in review). American Journal of Therapeutics 11(1): 9-12.

13.         Nurnberg HG, Hensley PH, Paine S, Siegel R: Effects of Sildenafil Citrate on Ejaculatory Delay and Erectile Dysfunction in Serotonergic Antidepressant-Associated Sexual Dysfunction. European Urology (2005) Vol.4, No.3(s): 542.

14.         Nurnberg HG, Siegel R: Phosphodiesterase Type 5 Inhibitor Treatment of Erectile Dysfunction May Impart Long-Term Benefits for Patients with Depression. J Androl (2005) 26:2(s), 102-103.

15.         Nurnberg HG, Segraves RT, Levine S, Frey N, Natanegara F, Wong DG, Abuja S: Tadalafil Is Efficacious for the Treatment of Erectile Dysfunction in a Population of Patients with Comorbid Clinical Depression: Results from Momentus.  J Sex Med (2006) Vol. 3 (suppl 1): 14-69.

16.         Nurnberg HG, Fava M, Gelenberg A, Hensley P, Sildenafil Salvage of Partial- and Nonresponders to Double Blind Sildenafil of Placebo Treatment of Serotonergic Antidepressant-Associated Sexual Dysfunction: Quantifying non-specific (placebo) treatment effects.  J Andrology (March/April 2006) 91.

17.         Nurnberg HG, Hensley PL, Fava M,  Croft H, Heiman J, Debattista C, Menza M, Warnock J, Sildenafil Treatment of Serotonergic Antidepressant Associated Sexual Dysfunction in Women with Major Depression Disorder in Remission: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial with 8-Week Open-Label Continuation.  The Journal of Urology (April 2006) 175:4.

18.         Bogenschutz MP, Nurnberg HG. (2004) Olanzapine versus placebo in the treatment of  borderline personality disorder. Journal of Clinical Psychiatry,  65:1

19.         Fava M, Nurnberg HG, Seidman S, Holloway W, Nicholas S, Tseng L, Stecher V: Efficacy and Safety of Sildenafil in Men With Serotonergic Antidepressant-Associated Erectile Dysfunction: Results from a Randomized, Double-Blind, Placebo-Controlled Trial.  J Clin Psychiatry (February 2006) 67:2, 240-246.

20.         Cappelleri J, Nurnberg HG, Tseng L, Tellier C, Siegel R, Efficacy of Sildenafil for the Treatment of Erectile Dysfunction in Men Taken Antidepressant Medication: Meta-analysis of Randomized, Double-blind, Placebo-controlled Studies.  J Andrology (March/April 2006) 64.

21.         Nurnberg HG, Segraves T, Levine S, Frey N, Natanegara F, Wong D, Abuja S (2004): Tadalafil is efficacious for treatment of erectile dysfunction in a population of patients with comorbid depression. Journal of Sexual Medicine  Vol.2, (Suppl 1) p.45.

Updated